1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Recombinant Therapeutic Antibodies and Proteins Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Plasma Protein
        1.2.3 Fusion Proteins
        1.2.4 Monoclonal Antibodies
        1.2.5 Hormones
        1.2.6 Enzyme
        1.2.7 Coagulation Factors
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Recombinant Therapeutic Antibodies and Proteins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Hematology
        1.3.4 Immunology
        1.3.5 Endocrinology
        1.3.6 Infectious Disease
        1.3.7 Cardiovascular Disease
        1.3.8 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Recombinant Therapeutic Antibodies and Proteins Market Perspective (2017-2028)
    2.2 Recombinant Therapeutic Antibodies and Proteins Growth Trends by Region
        2.2.1 Recombinant Therapeutic Antibodies and Proteins Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Recombinant Therapeutic Antibodies and Proteins Historic Market Size by Region (2017-2022)
        2.2.3 Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Region (2023-2028)
    2.3 Recombinant Therapeutic Antibodies and Proteins Market Dynamics
        2.3.1 Recombinant Therapeutic Antibodies and Proteins Industry Trends
        2.3.2 Recombinant Therapeutic Antibodies and Proteins Market Drivers
        2.3.3 Recombinant Therapeutic Antibodies and Proteins Market Challenges
        2.3.4 Recombinant Therapeutic Antibodies and Proteins Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Recombinant Therapeutic Antibodies and Proteins Players by Revenue
        3.1.1 Global Top Recombinant Therapeutic Antibodies and Proteins Players by Revenue (2017-2022)
        3.1.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Players (2017-2022)
    3.2 Global Recombinant Therapeutic Antibodies and Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Recombinant Therapeutic Antibodies and Proteins Revenue
    3.4 Global Recombinant Therapeutic Antibodies and Proteins Market Concentration Ratio
        3.4.1 Global Recombinant Therapeutic Antibodies and Proteins Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Recombinant Therapeutic Antibodies and Proteins Revenue in 2021
    3.5 Recombinant Therapeutic Antibodies and Proteins Key Players Head office and Area Served
    3.6 Key Players Recombinant Therapeutic Antibodies and Proteins Product Solution and Service
    3.7 Date of Enter into Recombinant Therapeutic Antibodies and Proteins Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Therapeutic Antibodies and Proteins Breakdown Data by Type
    4.1 Global Recombinant Therapeutic Antibodies and Proteins Historic Market Size by Type (2017-2022)
    4.2 Global Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Type (2023-2028)
5 Recombinant Therapeutic Antibodies and Proteins Breakdown Data by Application
    5.1 Global Recombinant Therapeutic Antibodies and Proteins Historic Market Size by Application (2017-2022)
    5.2 Global Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Recombinant Therapeutic Antibodies and Proteins Market Size (2017-2028)
    6.2 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Type
        6.2.1 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2017-2022)
        6.2.2 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2023-2028)
        6.2.3 North America Recombinant Therapeutic Antibodies and Proteins Market Share by Type (2017-2028)
    6.3 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Application
        6.3.1 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2017-2022)
        6.3.2 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2023-2028)
        6.3.3 North America Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2017-2028)
    6.4 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Country
        6.4.1 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2017-2022)
        6.4.2 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Recombinant Therapeutic Antibodies and Proteins Market Size (2017-2028)
    7.2 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Type
        7.2.1 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2017-2022)
        7.2.2 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2023-2028)
        7.2.3 Europe Recombinant Therapeutic Antibodies and Proteins Market Share by Type (2017-2028)
    7.3 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Application
        7.3.1 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2017-2022)
        7.3.2 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2023-2028)
        7.3.3 Europe Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2017-2028)
    7.4 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Country
        7.4.1 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2017-2022)
        7.4.2 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size (2017-2028)
    8.2 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Type
        8.2.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Share by Type (2017-2028)
    8.3 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Application
        8.3.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2017-2028)
    8.4 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Region
        8.4.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size (2017-2028)
    9.2 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Type
        9.2.1 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2017-2022)
        9.2.2 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2023-2028)
        9.2.3 Latin America Recombinant Therapeutic Antibodies and Proteins Market Share by Type (2017-2028)
    9.3 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Application
        9.3.1 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2017-2022)
        9.3.2 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2023-2028)
        9.3.3 Latin America Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2017-2028)
    9.4 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Country
        9.4.1 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2017-2022)
        9.4.2 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size (2017-2028)
    10.2 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Type
        10.2.1 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Share by Type (2017-2028)
    10.3 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Application
        10.3.1 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2017-2028)
    10.4 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Country
        10.4.1 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Recombinant Therapeutic Antibodies and Proteins Introduction
        11.1.4 Abbott Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
        11.1.5 Abbott Recent Developments
    11.2 Amgen
        11.2.1 Amgen Company Details
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Recombinant Therapeutic Antibodies and Proteins Introduction
        11.2.4 Amgen Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
        11.2.5 Amgen Recent Developments
    11.3 Biogen
        11.3.1 Biogen Company Details
        11.3.2 Biogen Business Overview
        11.3.3 Biogen Recombinant Therapeutic Antibodies and Proteins Introduction
        11.3.4 Biogen Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
        11.3.5 Biogen Recent Developments
    11.4 Eli Lilly
        11.4.1 Eli Lilly Company Details
        11.4.2 Eli Lilly Business Overview
        11.4.3 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Introduction
        11.4.4 Eli Lilly Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
        11.4.5 Eli Lilly Recent Developments
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Recombinant Therapeutic Antibodies and Proteins Introduction
        11.5.4 Roche Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
        11.5.5 Roche Recent Developments
    11.6 Johnson and Johnson
        11.6.1 Johnson and Johnson Company Details
        11.6.2 Johnson and Johnson Business Overview
        11.6.3 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Introduction
        11.6.4 Johnson and Johnson Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
        11.6.5 Johnson and Johnson Recent Developments
    11.7 Merck
        11.7.1 Merck Company Details
        11.7.2 Merck Business Overview
        11.7.3 Merck Recombinant Therapeutic Antibodies and Proteins Introduction
        11.7.4 Merck Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
        11.7.5 Merck Recent Developments
    11.8 Novo Nordisk
        11.8.1 Novo Nordisk Company Details
        11.8.2 Novo Nordisk Business Overview
        11.8.3 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Introduction
        11.8.4 Novo Nordisk Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
        11.8.5 Novo Nordisk Recent Developments
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Recombinant Therapeutic Antibodies and Proteins Introduction
        11.9.4 Pfizer Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
        11.9.5 Pfizer Recent Developments
    11.10 Sanofi
        11.10.1 Sanofi Company Details
        11.10.2 Sanofi Business Overview
        11.10.3 Sanofi Recombinant Therapeutic Antibodies and Proteins Introduction
        11.10.4 Sanofi Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
        11.10.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Recombinant Therapeutic Antibodies and Proteins Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Plasma Protein
    Table 3. Key Players of Fusion Proteins
    Table 4. Key Players of Monoclonal Antibodies
    Table 5. Key Players of Hormones
    Table 6. Key Players of Enzyme
    Table 7. Key Players of Coagulation Factors
    Table 8. Key Players of Others
    Table 9. Global Recombinant Therapeutic Antibodies and Proteins Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global Recombinant Therapeutic Antibodies and Proteins Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Recombinant Therapeutic Antibodies and Proteins Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Region (2017-2022)
    Table 13. Global Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Region (2023-2028)
    Table 15. Recombinant Therapeutic Antibodies and Proteins Market Trends
    Table 16. Recombinant Therapeutic Antibodies and Proteins Market Drivers
    Table 17. Recombinant Therapeutic Antibodies and Proteins Market Challenges
    Table 18. Recombinant Therapeutic Antibodies and Proteins Market Restraints
    Table 19. Global Recombinant Therapeutic Antibodies and Proteins Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Players (2017-2022)
    Table 21. Global Top Recombinant Therapeutic Antibodies and Proteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Therapeutic Antibodies and Proteins as of 2021)
    Table 22. Ranking of Global Top Recombinant Therapeutic Antibodies and Proteins Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Recombinant Therapeutic Antibodies and Proteins Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Recombinant Therapeutic Antibodies and Proteins Product Solution and Service
    Table 26. Date of Enter into Recombinant Therapeutic Antibodies and Proteins Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Type (2017-2022)
    Table 30. Global Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Type (2023-2028)
    Table 32. Global Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Application (2017-2022)
    Table 34. Global Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Application (2023-2028)
    Table 36. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2023-2028) & (US$ Million)
    Table 66. Abbott Company Details
    Table 67. Abbott Business Overview
    Table 68. Abbott Recombinant Therapeutic Antibodies and Proteins Product
    Table 69. Abbott Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022) & (US$ Million)
    Table 70. Abbott Recent Developments
    Table 71. Amgen Company Details
    Table 72. Amgen Business Overview
    Table 73. Amgen Recombinant Therapeutic Antibodies and Proteins Product
    Table 74. Amgen Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022) & (US$ Million)
    Table 75. Amgen Recent Developments
    Table 76. Biogen Company Details
    Table 77. Biogen Business Overview
    Table 78. Biogen Recombinant Therapeutic Antibodies and Proteins Product
    Table 79. Biogen Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022) & (US$ Million)
    Table 80. Biogen Recent Developments
    Table 81. Eli Lilly Company Details
    Table 82. Eli Lilly Business Overview
    Table 83. Eli Lilly Recombinant Therapeutic Antibodies and Proteins Product
    Table 84. Eli Lilly Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022) & (US$ Million)
    Table 85. Eli Lilly Recent Developments
    Table 86. Roche Company Details
    Table 87. Roche Business Overview
    Table 88. Roche Recombinant Therapeutic Antibodies and Proteins Product
    Table 89. Roche Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022) & (US$ Million)
    Table 90. Roche Recent Developments
    Table 91. Johnson and Johnson Company Details
    Table 92. Johnson and Johnson Business Overview
    Table 93. Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Product
    Table 94. Johnson and Johnson Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022) & (US$ Million)
    Table 95. Johnson and Johnson Recent Developments
    Table 96. Merck Company Details
    Table 97. Merck Business Overview
    Table 98. Merck Recombinant Therapeutic Antibodies and Proteins Product
    Table 99. Merck Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022) & (US$ Million)
    Table 100. Merck Recent Developments
    Table 101. Novo Nordisk Company Details
    Table 102. Novo Nordisk Business Overview
    Table 103. Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Product
    Table 104. Novo Nordisk Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022) & (US$ Million)
    Table 105. Novo Nordisk Recent Developments
    Table 106. Pfizer Company Details
    Table 107. Pfizer Business Overview
    Table 108. Pfizer Recombinant Therapeutic Antibodies and Proteins Product
    Table 109. Pfizer Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022) & (US$ Million)
    Table 110. Pfizer Recent Developments
    Table 111. Sanofi Company Details
    Table 112. Sanofi Business Overview
    Table 113. Sanofi Recombinant Therapeutic Antibodies and Proteins Product
    Table 114. Sanofi Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022) & (US$ Million)
    Table 115. Sanofi Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Type: 2021 VS 2028
    Figure 2. Plasma Protein Features
    Figure 3. Fusion Proteins Features
    Figure 4. Monoclonal Antibodies Features
    Figure 5. Hormones Features
    Figure 6. Enzyme Features
    Figure 7. Coagulation Factors Features
    Figure 8. Others Features
    Figure 9. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Application: 2021 VS 2028
    Figure 10. Oncology Case Studies
    Figure 11. Hematology Case Studies
    Figure 12. Immunology Case Studies
    Figure 13. Endocrinology Case Studies
    Figure 14. Infectious Disease Case Studies
    Figure 15. Cardiovascular Disease Case Studies
    Figure 16. Others Case Studies
    Figure 17. Recombinant Therapeutic Antibodies and Proteins Report Years Considered
    Figure 18. Global Recombinant Therapeutic Antibodies and Proteins Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 19. Global Recombinant Therapeutic Antibodies and Proteins Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 20. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Region: 2021 VS 2028
    Figure 21. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Players in 2021
    Figure 22. Global Top Recombinant Therapeutic Antibodies and Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Therapeutic Antibodies and Proteins as of 2021)
    Figure 23. The Top 10 and 5 Players Market Share by Recombinant Therapeutic Antibodies and Proteins Revenue in 2021
    Figure 24. North America Recombinant Therapeutic Antibodies and Proteins Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. North America Recombinant Therapeutic Antibodies and Proteins Market Size Market Share by Type (2017-2028)
    Figure 26. North America Recombinant Therapeutic Antibodies and Proteins Market Size Market Share by Application (2017-2028)
    Figure 27. North America Recombinant Therapeutic Antibodies and Proteins Market Size Share by Country (2017-2028)
    Figure 28. United States Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Canada Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Europe Recombinant Therapeutic Antibodies and Proteins Market Size YoY (2017-2028) & (US$ Million)
    Figure 31. Europe Recombinant Therapeutic Antibodies and Proteins Market Size Market Share by Type (2017-2028)
    Figure 32. Europe Recombinant Therapeutic Antibodies and Proteins Market Size Market Share by Application (2017-2028)
    Figure 33. Europe Recombinant Therapeutic Antibodies and Proteins Market Size Share by Country (2017-2028)
    Figure 34. Germany Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. France Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. U.K. Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Italy Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Russia Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Nordic Countries Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size YoY (2017-2028) & (US$ Million)
    Figure 41. Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market Size Market Share by Type (2017-2028)
    Figure 42. Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market Size Market Share by Application (2017-2028)
    Figure 43. Asia Pacific Recombinant Therapeutic Antibodies and Proteins Market Size Share by Region (2017-2028)
    Figure 44. China Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Japan Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. South Korea Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Southeast Asia Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. India Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Australia Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 50. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size Market Share by Type (2017-2028)
    Figure 52. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size Market Share by Application (2017-2028)
    Figure 53. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size Share by Country (2017-2028)
    Figure 54. Mexico Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Brazil Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size YoY (2017-2028) & (US$ Million)
    Figure 57. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Size Market Share by Type (2017-2028)
    Figure 58. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Size Market Share by Application (2017-2028)
    Figure 59. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Market Size Share by Country (2017-2028)
    Figure 60. Turkey Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 61. Saudi Arabia Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 62. UAE Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 63. Abbott Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
    Figure 64. Amgen Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
    Figure 65. Biogen Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
    Figure 66. Eli Lilly Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
    Figure 67. Roche Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
    Figure 68. Johnson and Johnson Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
    Figure 69. Merck Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
    Figure 70. Novo Nordisk Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
    Figure 71. Pfizer Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
    Figure 72. Sanofi Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed